Hikma’s diversified business delivers resilient H1 performance . Hikma’s diversified business delivers resilient H1 performance AETOSWire 4 August، 2022 London, United Kingdom — Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its... Read More Read more about Hikma’s diversified business delivers resilient H1 performance